The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy
ConditionEpilepsy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNeuronostics Ltd
About this trial
Neuronostics plan a prospective multisite trial to determine the clinical utility of BioEP in the context of diagnostic decision making. Neuronostics will use findings from the trial to improve user experience of the Neuronostics platform (the tool which clinicians use to obtain a BioEP score from EEG and the aligned report). The data coming from the trial will also enable Neuronostics to iterate the BioEP algorithms and so improve future performance.
Eligibility criteria
Qualifiers
Adult (age 18 and above) presenting with first suspected seizure(s)
Able to give informed consent
Patient receives EEG following clinicians' decision to refer for an EEG based on clinical history and seizure description taken during first seizure clinic.
Non-contributory EEG only (i.e. no specific diagnostic abnormalities present such as interictal epileptiform discharges)
Disqualifiers
Participants unable to tolerate an EEG test so no EEG data were gathered
Participants with a known hepatic/renal encephalopathy
Participants that upon history taking have a clear clinical diagnosis of a physical condition other than epilepsy (e.g. vasovagal syncope)
Trial design
Treatments tested in this trial
- BioEP
Treatment groups
559 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov